Es gab 50 kürzliche Insider-Transaktionen für Xenon Pharmaceuticals Inc. (XENE), darunter 28 Käufe und 20 Verkäufe. Die gesamten Insider-Käufe beliefen sich auf $23.98M und die gesamten Insider-Verkäufe auf $4.33M.
Bedeutende Insider mit kürzlicher Aktivität umfassen Mortimer Ian, Difabio Andrea, Kenney Christopher John. Insider-Transaktionen können Einblicke geben, wie die Unternehmensführung die Bewertung und Zukunftsaussichten der Aktie einschätzt.
Insider-Transaktionen — XENE
| Datum |
Name |
Funktion |
Transaktionsart |
Aktien |
Ø Preis |
Wert |
Gehaltene Aktien |
| 2026-03-13 |
Mortimer Ian |
President & CEO |
Informierter Verkauf |
7,308 |
$55.23 |
$403.58K |
19,923 |
| 2026-03-13 |
Difabio Andrea |
Chief Legal Officer |
Informierter Verkauf |
1,342 |
$55.23 |
$74.11K |
7,301 |
| 2026-03-13 |
Kenney Christopher John |
Chief Medical Officer |
Informierter Verkauf |
1,410 |
$55.23 |
$77.87K |
7,069 |
| 2026-03-12 |
Mortimer Ian |
President & CEO |
Optionsausübung |
12,500 |
- |
- |
27,231 |
| 2026-03-12 |
Difabio Andrea |
Chief Legal Officer |
Optionsausübung |
3,750 |
- |
- |
8,643 |
| 2026-03-12 |
Kenney Christopher John |
Chief Medical Officer |
Optionsausübung |
3,750 |
- |
- |
8,479 |
| 2026-03-10 |
Mortimer Ian |
President & CEO |
Informierter Verkauf |
11,269 |
$60.11 |
$677.36K |
14,731 |
| 2026-03-10 |
Difabio Andrea |
Chief Legal Officer |
Informierter Verkauf |
2,607 |
$60.11 |
$156.7K |
4,893 |
| 2026-03-10 |
Kenney Christopher John |
Chief Medical Officer |
Informierter Verkauf |
2,771 |
$60.11 |
$166.56K |
4,729 |
| 2026-03-09 |
Mortimer Ian |
President & CEO |
Optionsausübung (Verkauf) |
20,000 |
- |
- |
- |
| 2026-03-09 |
Difabio Andrea |
Chief Legal Officer |
Optionsausübung (Verkauf) |
7,500 |
- |
- |
- |
| 2026-03-09 |
Kenney Christopher John |
Chief Medical Officer |
Optionsausübung (Verkauf) |
7,500 |
- |
- |
- |
| 2026-01-09 |
Mortimer Ian |
President & CEO |
RSU-Zuteilung |
65,000 |
- |
- |
65,000 |
| 2026-01-09 |
Cline Darren S |
Chief Commercial Officer |
RSU-Zuteilung |
20,000 |
- |
- |
20,000 |
| 2026-01-09 |
Difabio Andrea |
Chief Legal Officer |
RSU-Zuteilung |
15,000 |
- |
- |
15,000 |
| 2026-01-09 |
Kenney Christopher John |
Chief Medical Officer |
RSU-Zuteilung |
20,000 |
- |
- |
20,000 |
| 2026-01-02 |
Mortimer Ian |
President & CEO |
Optionsausübung (Verkauf) |
40,000 |
$7.49 |
$299.6K |
- |
| 2025-12-08 |
Mortimer Ian |
President & CEO |
Informierter Verkauf |
2,010 |
$46.32 |
$93.1K |
6,000 |
| 2025-12-05 |
Mortimer Ian |
President & CEO |
Informierter Verkauf |
14,375 |
$45.03 |
$647.31K |
16,830 |
| 2025-11-28 |
Mortimer Ian |
President & CEO |
Informierter Verkauf |
97 |
$45.01 |
$4.37K |
31,205 |
| 2025-10-15 |
Kelly Thomas Patrick |
Chief Financial Officer |
Unbekannt |
- |
- |
- |
- |
| 2025-10-15 |
Kelly Thomas Patrick |
Chief Financial Officer |
RSU-Zuteilung |
30,000 |
- |
- |
30,000 |
| 2025-10-01 |
Mortimer Ian |
President, CEO & Interim CFO |
Optionsausübung (Verkauf) |
25,000 |
$7.69 |
$192.25K |
- |
| 2025-06-23 |
Cline Darren S |
Chief Commercial Officer |
Unbekannt |
- |
- |
- |
- |
| 2025-06-23 |
Cline Darren S |
Chief Commercial Officer |
RSU-Zuteilung |
185,800 |
$31.49 |
$5.85M |
185,800 |
| 2025-06-05 |
Patou Gary |
Director |
RSU-Zuteilung |
2,645 |
- |
- |
2,645 |
| 2025-06-05 |
Machado Patrick |
Director |
RSU-Zuteilung |
2,645 |
- |
- |
2,645 |
| 2025-06-05 |
Svoronos Dawn |
Director |
RSU-Zuteilung |
2,645 |
- |
- |
2,645 |
| 2025-06-05 |
Gannon Steven |
Director |
RSU-Zuteilung |
2,645 |
- |
- |
2,645 |
| 2025-06-05 |
Gover Justin D. |
Director |
RSU-Zuteilung |
2,645 |
- |
- |
2,645 |
| 2025-06-05 |
Garofalo Elizabeth A. |
Director |
RSU-Zuteilung |
2,645 |
- |
- |
2,645 |
| 2025-06-05 |
Cannon Gillian |
Director |
RSU-Zuteilung |
2,645 |
- |
- |
2,645 |
| 2025-05-14 |
Gannon Steven |
Director |
Optionsausübung (Verkauf) |
5,144 |
$12.57 |
$64.66K |
- |
| 2025-03-12 |
Mortimer Ian |
President & CEO |
RSU-Zuteilung |
50,000 |
- |
- |
50,000 |
| 2025-03-12 |
Difabio Andrea |
Chief Legal Officer |
RSU-Zuteilung |
15,000 |
- |
- |
15,000 |
| 2025-03-12 |
Kenney Christopher John |
Chief Medical Officer |
RSU-Zuteilung |
15,000 |
- |
- |
15,000 |
| 2025-01-27 |
Mortimer Ian |
President & CEO |
Optionsausübung (Verkauf) |
16,315 |
$17.76 |
$289.75K |
- |
| 2025-01-24 |
Mortimer Ian |
President & CEO |
Optionsausübung (Verkauf) |
22,468 |
$17.76 |
$399.03K |
16,315 |
| 2025-01-23 |
Mortimer Ian |
President & CEO |
Informierter Verkauf |
16,217 |
$40.08 |
$649.98K |
31,302 |
| 2024-12-18 |
Aulin Sherry |
Chief Financial Officer |
Optionsausübung (Verkauf) |
9,334 |
$9.44 |
$88.11K |
- |
| 2024-11-22 |
Patou Gary |
Director |
Optionsausübung (Verkauf) |
3,086 |
$13.48 |
$41.6K |
- |
| 2024-06-05 |
Patou Gary |
Director |
RSU-Zuteilung |
15,542 |
$38.16 |
$593.08K |
15,542 |
| 2024-06-05 |
Machado Patrick |
Director |
RSU-Zuteilung |
15,542 |
$38.16 |
$593.08K |
15,542 |
| 2024-06-05 |
Svoronos Dawn |
Director |
RSU-Zuteilung |
15,542 |
$38.16 |
$593.08K |
15,542 |
| 2024-06-05 |
Gannon Steven |
Director |
RSU-Zuteilung |
15,542 |
$38.16 |
$593.08K |
15,542 |
| 2024-06-05 |
Gover Justin D. |
Director |
RSU-Zuteilung |
15,542 |
$38.16 |
$593.08K |
15,542 |
| 2024-06-05 |
Garofalo Elizabeth A. |
Director |
RSU-Zuteilung |
15,542 |
$38.16 |
$593.08K |
15,542 |
| 2024-06-05 |
Cannon Gillian |
Director |
RSU-Zuteilung |
15,542 |
$38.16 |
$593.08K |
15,542 |
| 2024-03-11 |
Mortimer Ian |
President & CEO |
RSU-Zuteilung |
250,000 |
$44.37 |
$11.09M |
250,000 |
| 2024-03-11 |
Robin Sherrington |
EVP, Strategy & Innovation |
RSU-Zuteilung |
65,000 |
$44.37 |
$2.88M |
65,000 |
■ Informativ — Transaktion am offenen Markt (bedeutendste)
■ Nicht-informativ (Kauf) — Vergütung, Optionsausübung, Wandlung
■ Nicht-informativ (Verkauf) — Quellensteuer, Verkauf bei Vesting
■ Neutral — Schenkung, Treuhand, Verfall
